News & Analysis as of

Off-Label Use Corporate Counsel

BakerHostetler

Amarin Pharma Sues FDA Over Constitutional Right to Discuss Off-Label Uses

BakerHostetler on

Drug makers and the Food and Drug Administration (FDA) have often disagreed over whether drug makers can discuss unapproved uses for their products with physicians. While courts have sided with drug makers in certain...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide